Pfizer’s Partner BioNTech Signs Research Pact With Australia

Pfizer Inc’s (NYSE:PFE) COVID-19 partner BioNTech SE (NASDAQ:BNTX) will set up research and manufacturing centers in Australia. BioNTech and Australia’s Victoria state signed…
  • Pfizer Inc’s (NYSE:PFE) COVID-19 partner BioNTech SE (NASDAQ:BNTX) will set up research and manufacturing centers in Australia.
  • BioNTech and Australia’s Victoria state signed a partnership to create a center to run clinical research of experimental messenger ribonucleic acid (mRNA), vaccines, and therapies.
  • The partnership would also involve setting up mRNA manufacturing facilities in Melbourne.
  • As part of this collaboration, the State of Victoria and BioNTech will establish a research and innovation center, directed in partnership with the State, to support Australia’s mRNA ecosystem by curating projects and to determine their potential transition into preclinical and clinical development, supported by BioNTech’s advice and know-how. 
  • The partnership will also include the research and development of experimental therapies, including mRNA-based product candidates for indications. 
  • BioNTech will support the R&D efforts on a project-by-project basis with the company’s expertise in mRNA research and clinical development of potential new products.
  • Price Action: BNTX shares are down 1.27% at $135.87 on the last check Friday.
Total
0
Shares
Related Posts
Read More

Steel Products Maker Nucor Acquires Southwest Data Products For $115M

Nucor Corporation expands its footprint in the data center infrastructure industry with the acquisition of Southwest Data Products, Inc. (SWDP) for $115 million, marking the launch of Nucor Data Systems. This strategic move strengthens Nucor's position as a key supplier to major cloud and colocation data center operators, enhancing its capabilities in airflow containment structures and installation services.

NUE